DR. INFO and OpenEvidence, side by side
Available in Poland
DR. INFO Yes, on the web and the iPhone app
OpenEvidence No, access from the EU ended 28 April 2026
Answers in Polish
DR. INFO Yes, in the language you ask in
OpenEvidence No, English only
How it answers
DR. INFO A written answer built from retrieved guidelines and literature, each statement cited
OpenEvidence A written answer with citations, US-oriented sources
Data hosting
DR. INFO European Union, under GDPR
OpenEvidence United States
Guideline sources
DR. INFO European and national guidelines, retrieved per question; Polish society guidelines and the ESC guidelines they adopt can be asked about
OpenEvidence US-centred
Drug information
DR. INFO FDA and EMA authorised sources, EMA SmPC; the Polish Rejestr Produktów Leczniczych remains the national reference
OpenEvidence US sources
Documentation
DR. INFO Scribe with SOAP notes and discharge letters in the same product
OpenEvidence None
Regulatory status
DR. INFO CE marked medical device under EU MDR 2017/745, which applies directly in Poland
OpenEvidence Not CE marked
HealthBench Hard (same 100 examples)
DR. INFO 0.72
OpenEvidence 0.49
Cost
DR. INFO Free tier, paid plans
OpenEvidence Was free for verified clinicians
| DR. INFO | OpenEvidence | |
|---|---|---|
| Available in Poland | Yes, on the web and the iPhone app | No, access from the EU ended 28 April 2026 |
| Answers in Polish | Yes, in the language you ask in | No, English only |
| How it answers | A written answer built from retrieved guidelines and literature, each statement cited | A written answer with citations, US-oriented sources |
| Data hosting | European Union, under GDPR | United States |
| Guideline sources | European and national guidelines, retrieved per question; Polish society guidelines and the ESC guidelines they adopt can be asked about | US-centred |
| Drug information | FDA and EMA authorised sources, EMA SmPC; the Polish Rejestr Produktów Leczniczych remains the national reference | US sources |
| Documentation | Scribe with SOAP notes and discharge letters in the same product | None |
| Regulatory status | CE marked medical device under EU MDR 2017/745, which applies directly in Poland | Not CE marked |
| HealthBench Hard (same 100 examples) | 0.72 | 0.49 |
| Cost | Free tier, paid plans | Was free for verified clinicians |
How DR. INFO compares with OpenEvidence
Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.
Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.
Frequently asked questions
- Is OpenEvidence available in Poland in 2026?
- No. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, and access from Polish and other European addresses has been blocked since. The company cited regulatory uncertainty around European AI rules. No return date has been announced.
- Is there a Polish version of OpenEvidence?
- No. OpenEvidence never answered in Polish or offered a Polish interface, and its sources were US-oriented. Searches for OpenEvidence po polsku lead back to the April 2026 withdrawal. DR. INFO answers in the language you ask in, so a question in Polish gets a cited answer in Polish.
- Does the OpenEvidence app still work in Poland?
- No. The app can be installed, but sign-in and access from EU addresses have been blocked since April 2026, in the app and in the browser alike. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app, from Poland without workarounds.
- When will OpenEvidence come back to Poland?
- There is no date. The withdrawal was tied to European AI regulation, whose obligations for medical AI phase in through 2027, so a return would be a decision by the company rather than a technical fix. A clinician who needs a cited answer today is better off not waiting for it.
- Why did OpenEvidence leave Europe?
- OpenEvidence withdrew from the EU and the UK together, citing uncertainty about European AI regulation, including the EU AI Act. Commentary in the medical press has treated the move as a sign of the regulatory divide between US health AI and European rules [7].
- What do Polish doctors use instead of OpenEvidence?
- Two kinds of tool. The Polish references: Medycyna Praktyczna, whose Interna Szczeklika, Indeks Leków and Polish editions of society guidelines are the everyday desk reference [4], the Rejestr Produktów Leczniczych for authorised products, and the guidelines of societies such as the Polish Cardiac Society, which adopts the ESC guidelines, all written to be consulted. And DR. INFO, a European clinical AI that answers a clinical question in Polish with citations you can open, hosts data in the EU, and includes a scribe and discharge letter drafting.
- Is DR. INFO the best OpenEvidence alternative for Polish doctors?
- For a clinician who wants what OpenEvidence did, a cited written answer to a clinical question, DR. INFO is the closest fit that can be used from Poland: it retrieves guidelines and literature for each question, cites every statement, hosts data in the EU, answers in Polish and scored 0.72 against OpenEvidence's 0.49 on HealthBench Hard.
- How does DR. INFO cite its answers?
- Each answer is written from documents retrieved for that question, and each statement carries a citation that opens the source: a guideline, a peer reviewed paper, or an FDA or EMA drug document. That makes the answer checkable in the way a colleague's summary is not. In a prospective pilot study published in Cureus in 2026, physicians using DR. INFO at the point of care rated that traceability as part of its value [8].
- Can DR. INFO answer questions about Polish guidelines?
- Guidelines published by the Polish scientific societies are public documents, so DR. INFO can be asked about them and cites the source it used in the answer; with the country set to Poland, national recommendations are preferred, and European guidelines from bodies such as the ESC, which the Polish Cardiac Society adopts, are always included. Coverage is broad but not complete for any single society, and some Polish recommendations exist only in Polish journals. DR. INFO is not affiliated with any society, and the current guideline on its website remains the version to rely on.
- Where is DR. INFO's data hosted, and what does that mean for a Polish practice?
- DR. INFO is hosted in the European Union under GDPR, known in Poland as RODO and supervised by the Urząd Ochrony Danych Osobowych. Asking a clinical question without patient identifiers does not transfer health data. Whether a tool may be used with identifiable patient data remains a decision for each hospital, przychodnia or practice, with its data protection officer and with medical confidentiality under the Act on the Professions of Physician and Dentist in mind.
- Is DR. INFO free for doctors in Poland?
- There is a free tier for doctors, rezydenci and medical students, with paid plans for heavier use. It works in the browser at app.drinfo.ai and on the iPhone app, from Poland without restriction.
- Does DR. INFO answer in Polish?
- Yes. Ask in Polish and the answer comes back in Polish, with the same cited sources; ask in English and it answers in English. The product interface is currently available in English, German, Dutch and Portuguese.
- Is DR. INFO a certified medical device?
- Yes. DR. INFO is CE marked under EU MDR 2017/745 [9], which applies directly in Poland with the Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych as the competent authority, and is developed and operated by Synduct GmbH in Munich.
OpenEvidence is not coming back to Poland on any announced date, there was never a Polish version, and Interna Szczeklika and the Indeks Leków were never an answer engine. For a Polish clinician who wants a cited answer to a clinical question in Polish, DR. INFO is the tool to try first: built in Europe, hosted in the EU, free to start, and scoring higher than OpenEvidence on the hardest public benchmark of clinical answers.
References
- 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
- 2.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
- 3.Puls Medycyny. Ilu lekarzy jest w Polsce? MZ podało aktualne dane. 2026.
- 4.Medycyna Praktyczna. mp.pl: Interna Szczeklika, Indeks Leków i wytyczne dla lekarzy.
- 5.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
- 6.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
- 7.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
- 8.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
- 9.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.